Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 52% ± 19% | |
microglial cell | 11 studies | 28% ± 11% | |
endothelial cell | 8 studies | 20% ± 7% | |
macrophage | 8 studies | 29% ± 10% | |
astrocyte | 7 studies | 32% ± 11% | |
oligodendrocyte precursor cell | 6 studies | 27% ± 9% | |
GABAergic neuron | 4 studies | 39% ± 13% | |
glutamatergic neuron | 4 studies | 47% ± 19% | |
interneuron | 4 studies | 33% ± 18% | |
dendritic cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1218.02 | 2641 / 2642 | 100% | 23.51 | 704 / 705 |
ovary | 100% | 564.32 | 180 / 180 | 100% | 11.39 | 429 / 430 |
thymus | 100% | 804.76 | 653 / 653 | 100% | 16.45 | 603 / 605 |
breast | 100% | 609.54 | 458 / 459 | 100% | 15.03 | 1114 / 1118 |
bladder | 100% | 599.86 | 21 / 21 | 98% | 11.21 | 496 / 504 |
prostate | 99% | 523.46 | 242 / 245 | 100% | 13.23 | 500 / 502 |
uterus | 99% | 684.15 | 169 / 170 | 99% | 13.48 | 454 / 459 |
pancreas | 99% | 518.38 | 326 / 328 | 99% | 10.64 | 176 / 178 |
esophagus | 100% | 488.73 | 1439 / 1445 | 98% | 10.78 | 180 / 183 |
kidney | 100% | 551.74 | 89 / 89 | 98% | 13.48 | 881 / 901 |
liver | 99% | 440.41 | 224 / 226 | 98% | 9.01 | 399 / 406 |
stomach | 100% | 526.61 | 359 / 359 | 97% | 10.92 | 278 / 286 |
lung | 97% | 528.41 | 558 / 578 | 100% | 12.94 | 1155 / 1155 |
intestine | 100% | 611.71 | 966 / 966 | 96% | 10.20 | 507 / 527 |
skin | 98% | 536.59 | 1775 / 1809 | 96% | 17.40 | 451 / 472 |
adrenal gland | 98% | 588.84 | 252 / 258 | 94% | 7.97 | 216 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.98 | 29 / 29 |
spleen | 100% | 953.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.99 | 1 / 1 |
adipose | 100% | 661.84 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 605.76 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 333.04 | 811 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 18.23 | 75 / 80 |
muscle | 91% | 262.54 | 734 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 454.06 | 633 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000423 | Biological process | mitophagy |
GO_0006914 | Biological process | autophagy |
GO_0015031 | Biological process | protein transport |
GO_0016485 | Biological process | protein processing |
GO_0034727 | Biological process | piecemeal microautophagy of the nucleus |
GO_0006508 | Biological process | proteolysis |
GO_0006501 | Biological process | C-terminal protein lipidation |
GO_0035973 | Biological process | aggrephagy |
GO_0051697 | Biological process | protein delipidation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0005575 | Cellular component | cellular_component |
GO_0005737 | Cellular component | cytoplasm |
GO_0019786 | Molecular function | protein-phosphatidylethanolamide deconjugating activity |
GO_0008234 | Molecular function | cysteine-type peptidase activity |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ATG4C |
Protein name | Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C) Cysteine protease (EC 3.4.22.-) |
Synonyms | AUTL3 AUTL1 APG4C |
Description | FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins . The protease activity is required for proteolytic activation of ATG8 family proteins: cleaves the C-terminal amino acid of ATG8 proteins MAP1LC3 and GABARAPL2, to reveal a C-terminal glycine . Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy (By similarity). In addition to the protease activity, also mediates delipidation of ATG8 family proteins . Catalyzes delipidation of PE-conjugated forms of ATG8 proteins during macroautophagy . Compared to ATG4B, the major protein for proteolytic activation of ATG8 proteins, shows weaker ability to cleave the C-terminal amino acid of ATG8 proteins, while it displays stronger delipidation activity . In contrast to other members of the family, weakly or not involved in phagophore growth during mitophagy . . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . FUNCTION: Cysteine protease that plays a key role in autophagy by mediating both proteolytic activation and delipidation of ATG8 family proteins. . |
Accessions | Q96DT6 ENST00000371120.7 ENST00000317868.9 ENST00000443289.5 ENST00000414558.2 C9JC51 H7BZW5 A6NGQ4 Q05D29 ENST00000371118.1 |